NERV vs NEON โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
NERV Captures Institutional Edge (2โ2 Pillars ยท 5โ5 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Minerva Neurosciences, Inc (NERV) driven by superior Growth & Margin, Momentum & Technical while NEON counters with relative strength in Valuation, Options & Structure. Fundamentally, NERV trades at 11.2x Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus NEON at 9.3x Forward P/E and -604.4% operating margin (-20.4% YoY). In options structure, NERV sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against NEON sits in UNCLASSIFIED (50th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NERV | NEON | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $105.7M | $8.7M | Larger Scale | NERV |
| Trailing P/E Ratio Valuation | 11.2x | 9.3x | Lower Multiple | NEON |
| Forward P/E Ratio Valuation | 11.2x | 9.3x | Lower Multiple | NEON |
| Revenue Growth (YoY) Growth | +0.0% | -20.4% | Higher Growth | NERV |
| Operating Margin (TTM) Profitability | 0.0% | -604.4% | Higher Margin | NERV |
| Net Profit Margin Profitability | 0.0% | 397.8% | Higher Margin | NEON |
| Return on Equity (ROE) Capital Efficiency | -675.1% | 46.8% | Higher ROE | NEON |
| 52-Week Range Position Momentum | 1% ($2โ$9) | 0% ($0โ$2) | Stronger Trend | NERV |
| Beta / 30D Volatility Risk Regime | 1.63ฮฒ ยท 76% Vol | 2.07ฮฒ ยท 63% Vol | Lower Realized Risk | NEON |
| Unified Institutional Score Composite Signal | 43.3 / 100 (HOLD) | 39.8 / 100 (SELL) | Higher Composite | NERV |